Compare Hims and Hers Health Inc (HIMS) vs SoFi Technologies Inc (SOFI) Price & Performance

Hims & Hers Health trades at $29.54, up slightly by 0.24% on the day. The stock shows a bullish technical signal with moving averages supporting an uptrend, while oscillators remain neutral. Fundamentally, the company reported revenue of $2.35 billion in 2025 but swung to a net loss of $142 million in 2026, with a negative net margin of 5.51%. Analyst consensus is a 'Hold' with a price target of $32.17, but the stock faces significant headwinds from multiple securities class action lawsuits announced in early October 2026.

The outlook for HIMS is clouded by legal risks and profitability challenges despite revenue growth. Investment opportunity hinges on the company's ability to return to profitability and resolve regulatory scrutiny. Key risks include ongoing litigation, FTC complaints, and execution missteps in a competitive telehealth market. Wall Street remains cautious with 65% of analysts recommending Hold.

SoFi Technologies (SOFI) trades at $15.66, down 0.64% on the day and near its 52-week low, reflecting bearish technical signals. The company reported strong revenue growth to $3.61 billion in 2025 with a net income of $481.32 million, but negative operating cash flow and high leverage remain concerns. Analyst sentiment is mixed with a consensus price target of $21.58, implying significant upside, while recent news highlights growth in loan originations and stablecoin initiatives.

The outlook for SOFI hinges on sustaining profitability amid competitive pressures and interest rate sensitivity. Upside potential exists from execution on guidance and market share gains, but risks include persistent cash burn and macroeconomic headwinds. Investors should weigh the growth trajectory against valuation premiums and operational challenges.